title: Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
abstract: Analysis of nine mouse monoclonal antibodies (mAbs) to the thyrotropin receptor (TSHR) with TSH antagonist activity showed that only one of the mAbs (RSR B2) was an effective antagonist of the human thyroid stimulating autoantibody M22. Crystals of B2 Fab were analyzed by x-ray diffraction and a crystal structure at 3.3 A resolution was obtained. The surface charge and topography of the B2 antigen binding site were markedly different from those of the thyroid-stimulating mAb M22 and these differences might contribute to the different properties of the two mAbs. B2 (but not other mouse TSHR-specific mAbs) was also an effective antagonist of thyroid stimulating autoantibody activity in 14 of 14 different sera from patients with Graves' disease. 125I-labeled B2 bound to the TSHR with high affinity (2 x 10(10) L/mol) and patient serum TSHR autoantibodies inhibited labeled B2 binding to the receptor in a similar way to inhibition of labeled TSH binding (r = 0.75; n = 20). Furthermore, labeled B2 binding was inhibited by patient serum TSHR autoantibodies with TSH antagonist activity and also by mouse and human thyroid stimulating mAbs. Overall, mAb B2 is a powerful antagonist of thyroid stimulating autoantibodies (and TSH) thus resembling closely patient serum TSH antagonist TSHR autoantibodies. Furthermore, B2 might have potentially important in vivo applications when tissues containing the TSHR (including those in the orbit) need to be made unresponsive to stimulating autoantibodies.
authors.affiliation: FIRS Laboratories, RSR Ltd, Parc Ty Glas, Llanishen, Cardiff, United Kingdom.
authors.forename: J
authors.initials: J
authors.lastname: Sanders
authors.forename: F
authors.initials: F
authors.lastname: Allen
authors.forename: J
authors.initials: J
authors.lastname: Jeffreys
authors.forename: J
authors.initials: J
authors.lastname: Bolton
authors.forename: T
authors.initials: T
authors.lastname: Richards
authors.forename: H
authors.initials: H
authors.lastname: Depraetere
authors.forename: N
authors.initials: N
authors.lastname: Nakatake
authors.forename: M
authors.initials: M
authors.lastname: Evans
authors.forename: A
authors.initials: A
authors.lastname: Kiddie
authors.forename: L D K E
authors.initials: LD
authors.lastname: Premawardhana
authors.forename: D Y
authors.initials: DY
authors.lastname: Chirgadze
authors.forename: R Núñez
authors.initials: RN
authors.lastname: Miguel
authors.forename: T L
authors.initials: TL
authors.lastname: Blundell
authors.forename: J
authors.initials: J
authors.lastname: Furmaniak
authors.forename: B Rees
authors.initials: BR
authors.lastname: Smith
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D016466:CHO Cells; D006224:Cricetinae; D018360:Crystallography, X-Ray; D006111:Graves Disease / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry / Q000276:immunology; D007457:Iodine Radioisotopes; D051379:Mice; D017434:Protein Structure, Tertiary; D011989:Receptors, Thyrotropin / Q000276:immunology* / Q000378:metabolism; D013972:Thyrotropin / Q000276:immunology* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D007140:Immunoglobulin Fab Fragments; D007457:Iodine Radioisotopes; D011989:Receptors, Thyrotropin; D013972:Thyrotropin